ChronoScale Holdings Corp has made a significant move by entering into two private placement agreements aimed at raising up to $500 million. This funding will be crucial for the company's ongoing projects, particularly a data center being developed in Odessa, Texas. The agreements involve the sale of common and preferred stock, which will help bolster the company's capital structure and support its growth initiatives.
On November 18, 2026, ChronoScale Holdings Corporation, based in Menlo Park, California, filed an 8-K detailing these agreements. The company is classified under the SIC code 3569, which pertains to general industrial machinery and equipment. This strategic financing is expected to enhance its competitive position within the industry.
The filing reveals that the company has entered into a securities purchase agreement for the private placement of common stock at a price of $8.00 per share, expecting to raise approximately $153 million from the sale of about 19.1 million shares. Additionally, the firm has a preferred equity purchase agreement for the issuance of up to $500 million of newly designated Series C Preferred Stock.
Goldman Sachs & Co. LLC is acting as the lead placement agent for these private placements, with Northland Capital Markets serving as a co-placement agent. Other financial advisors involved include Lake Street Capital Markets and B. Riley Securities, as well as Lucid Capital Markets and Needham & Company.
The net proceeds from the common stock private placement will primarily fund the company's capital commitment to the new data center project, which includes the purchase of GPUs necessary for its operations. The preferred stock proceeds will be allocated for working capital and general corporate purposes.
Each purchase agreement includes standard representations and warranties, along with indemnification obligations. The company has also agreed to certain restrictions on issuing additional shares of common stock for a specified period, ensuring stability during this capital-raising phase.
ChronoScale's strategic move to secure substantial funding through these private placements may set a precedent in the general industrial machinery sector, where companies often seek innovative financing solutions to support growth and expansion. The filing does not specify what happens next, but the successful execution of these placements could lead to significant developments for the company and its stakeholders.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










